>what is the anticipated market for Atryn in the US HD indication?<
There is no formal guidance from the company. My best guess is that, within a couple of years of launch in each territory, the HD indication will produce gross annual sales of roughly $75M, of which $35M will be US, $25M EU/RoW, and $15M Japan.
Compared to the projected $1B+ of ATryn sales for the DIC indication in the US alone (#msg-19928950, #msg-22017312), you can see why it’s correct to say that HD is a small slice of the ATryn pie.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.